Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
This is a clear earnings release disclosing Travere Therapeutics' second quarter 2026 financial results. The filing explicitly states "Travere Therapeutics Reports Second Quarter 2026 Financial Results" and discloses key metrics including U.S. net product sales of $161.4 million (up from $94.8 million YoY), FILSPARI sales of $141.1 million (96% YoY growth), R&D and SG&A expenses, and net loss of $34.8 million. The press release is attached as Exhibit 99.1 and covers both financial results and material corporate updates including FDA approval of FILSPARI for FSGS and the in-licensing of civorebrutinib.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
Workiva issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing total revenue of $255 million (up 19% year-over-year), GAAP net income of $13 million (versus a loss of $19 million in the prior year), and non-GAAP operating margin of 16.8% (up from 3.8%). The press release is attached as Exhibit 99.1 and constitutes a standard quarterly earnings disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
This is a clear earnings release disclosing Otter Tail Corporation's consolidated financial results for the second quarter of 2026, issued on August 3, 2026. The press release reports quarterly diluted loss per share of $0.18 and adjusted diluted earnings per share of $1.66, updates annual EPS guidance to $3.84–$4.24, and provides detailed segment performance and 2026 outlook. The Item 2.02 disclosure explicitly states the press release is furnished as Exhibit 99.1, which is the standard format for earnings releases in 8-K filings.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-04
The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing financial results for the quarter ended June 30, 2026. The filing includes detailed quarterly and six-month financial statements showing net losses, revenue, and operating expenses, along with a corporate update on clinical development programs. This is a standard earnings release disclosure material to investors assessing the company's financial performance and operational progress.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-08-04
Item 7.01
Fusemachines announced a $2.5 million convertible note investment from Meteora Capital with a fixed $4.20 conversion price, combined with 2.05 million warrants at the same exercise price, potentially generating up to $10.66 million in total capital. The press release explicitly notes the potential dilution to existing stockholders from conversion and warrant exercise, and the financing structure—convertible debt plus warrants—is characteristic of dilutive equity issuances. While the Item 7.01 disclosure is furnished (not filed), the underlying transaction involves creation of convertible securities and warrants that will dilute existing shareholders upon conversion and exercise.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-04
Elite Pharmaceuticals announced the commercial launch of a generic version of Requip XL (Ropinirole Extended-Release Tablets) on August 4, 2026. This is a material operational and product milestone for a specialty pharmaceutical company, representing entry into a new market segment with an estimated $10 million annual market size. The event does not fit the specific categories of earnings release, M&A activity, or other named types, but clearly represents a significant operational development material to investors.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-08-04
EX-99.1
The exhibit announces that PowerBank's 903 BESS project has secured Official Plan Amendment and Zoning Bylaw Amendment approvals on July 21, 2026, representing a "significant regulatory milestone" and advancing the project toward construction expected in Q4 2026. This is a material operational and strategic milestone for a renewable energy developer—the project has a 22-year IESO contract at $1,221/MW per business day and represents PowerBank's second BESS project in Ontario to achieve this permitting stage. While not a discrete M&A transaction, debt issuance, or workforce event, this regulatory achievement is a material operational milestone that would affect a reasonable investor's assessment of the company's project development progress and pipeline execution capability.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-04
SharonAI announced a US$373 million five-year AI cloud service agreement with a global AI platform, representing a material contract win that expands the company's customer base and contracted AI infrastructure capacity. The filing discloses this under Item 7.01 (Regulation FD Disclosure) via press release. While this is a significant operational and commercial milestone for the company, it does not fit neatly into the specific event categories (not M&A, not a debt issuance, not a capital raise, not a workforce action). This is a material operational/strategic business event—a major customer contract—that warrants disclosure but falls under the operational domain rather than financial, legal, or governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-04
The filing discloses the appointment of two new independent directors, Craig Hart and Nancy Novak, to MARA's board effective August 1, 2026, filling vacancies created by the resignations of Barbara Humpton and Georges Antoun. While both departures and appointments occur, the principal disclosed action centers on the appointment of the new directors with detailed biographical information and their specific roles (Hart on the Risk and Audit Committee). This is a material governance event affecting board composition at a public company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-08-04
The filing discloses NextBoat Inc.'s announcement of its second quarter 2026 financial and operating results to be released on August 13, 2026, followed by an earnings conference call. Although this is technically an announcement of a future earnings release rather than the results themselves, the 8-K Item 7.01 disclosure and attached press release (Exhibit 99.1) center on the scheduled earnings announcement, which is a material event affecting investor information about the company's financial performance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-08-04
The filing discloses the launch of a global "Let's Play" pickleball and padel platform initiative involving potential acquisitions, strategic partnerships, and franchising opportunities across multiple international markets. While the company explicitly states it has not yet acquired any facilities or entered into definitive agreements, the announcement of this strategic expansion initiative—with named leadership (Stefanie Graf, Darren Cahill) and identified initial markets (Germany, Australia)—represents a material operational and strategic business development that would affect a reasonable investor's assessment of the company's direction and growth plans.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-08-04
EX-99.1
CBL International announced on August 3, 2026, that it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after previously receiving a delisting notice on August 12, 2025. The company effected a 1-for-13 reverse stock split on July 20, 2026, to cure the deficiency. While the announcement is positive (compliance regained), the underlying event is the resolution of a delisting risk that threatened the company's continued listing on Nasdaq, making this material to investors assessing the registrant's exchange listing status.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-08-04
The filing discloses a private placement of 61.1 million shares of common stock and 61.1 million warrants at $0.05 per share for gross proceeds of $3.055 million, conducted pursuant to Section 4(a)(2) and Rule 506(b) of Regulation D—a classic unregistered equity issuance. Item 3.02 explicitly confirms this as an "Unregistered Sale of Equity Securities." The substantial share count and warrant component represent significant dilution to existing shareholders.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-04
The filing discloses the completion of a material asset disposition on August 3, 2026, whereby Kustom Entertainment sold substantially all assets of its video-solutions division to Cycurion, Inc. for aggregate consideration of $6.1 million (comprising $1.25M cash, $4.25M secured promissory note, $600K preferred stock, and up to $1M earnout). This is a material acquisition/disposition event under Item 1.01 and Item 2.01, representing a strategic transformation of the company into a "pure-play live entertainment" business and elimination of a legacy operating division.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-08-04
The filing discloses multiple unregistered equity issuances in July 2026, including 700,000 shares to Streeterville (via Note Exchange), 386,145 shares to Horberg (via Series E Exchange), and conversions by 1800 Diagonal Lending totaling 610,042 shares, plus a 1,000,000 share issuance to Silverback Capital. These transactions under Item 3.02 represent substantial dilutive equity issuances exempt from registration under Section 4(a)(2) and Regulation D, typical of a small-cap company raising capital through private placements and debt conversions.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-08-04
The 6-K discloses the results of three shareholder meetings held on July 31, 2026: a Class A Ordinary Shares meeting, a Class B Ordinary Shares meeting, and an Extraordinary General Meeting. The primary matters voted on were (1) an increase of voting rights for Class B Ordinary Shares from 20 to 200 votes per share, and (2) adoption of amended and restated memorandum and articles of association. All proposals were approved by overwhelming majorities. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent, and the material change to voting rights structure makes it material to investors.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 85%
filed 2026-08-04
The filing discloses settlement of litigation commenced by former CFO Doug Durst in connection with his employment termination. The Company paid $247,500 in cash to Durst and $55,890 to his affiliate Chase Innovations, plus issued a warrant for 57,600 shares at $4.11 exercise price. This represents a material settlement of an employment-related dispute that would affect investor assessment of the registrant's legal and financial position.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-04
Shawn Matthews resigned from the Board of Directors of Streamex Corp. effective July 29, 2026. The filing explicitly states his departure was not due to disagreement with the Company. This is a clear executive departure under Item 5.02, with the principal disclosed action being a director leaving the Board.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-08-04
The filing discloses a board-approved extension of the deadline to consummate an initial business combination (from August 3, 2026 to September 3, 2026), the fourth of ten available monthly extensions, with a corresponding deposit of $13,897.14 into the trust account. This is a material event for a SPAC (special purpose acquisition company) as it directly affects the timeline and viability of the merger obligation, but it does not fit neatly into standard M&A categories since no specific business combination has been announced or consummated—rather, this is an administrative extension of the deadline itself.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-08-04
The filing discloses that Mangoceuticals received a deficiency notification from Nasdaq on February 4, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days. On August 4, 2026, the company received a Second Notice granting an additional 180-calendar-day compliance period until February 1, 2027, to regain compliance with the Bid Price Requirement. This is a material delisting risk disclosure under Item 8.01, as the company faces potential delisting if it fails to meet the minimum bid price requirement by the deadline.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-04
The 8-K discloses Item 2.02 (Results of Operations and Financial Condition) with a press release announcing Q2 2026 financial results for the quarter ended June 30, 2026. The press release includes key financial metrics (commission income, net loss, AEBITDA, balance sheet items) and a business update on AI platform development. This is a standard earnings release disclosure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-04
Item 1.01
Oncotelic Therapeutics entered into a Securities Purchase Agreement with Pacific Pier Capital II, LP on August 3, 2026, issuing a convertible promissory note of $178,410 principal amount convertible into common stock at $0.06 per share, plus 500,000 commitment shares. This unregistered private placement combines convertible debt and equity commitment shares that will dilute existing shareholders upon conversion and exercise.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-08-04
DataMeds AI entered into an Amended and Restated Letter of Intent on July 29, 2026 (Item 1.01) to acquire or exclusively license intellectual property assets from EOS and Scilex, expand its PharmacyChain license with Datavault, and acquire a controlling interest in Tollo Health through an exchange of membership interests. The transaction would result in the four counterparties owning approximately 84.6% of the Company's common stock post-closing, representing a material change of control. This is a classic M&A activity disclosure under Item 1.01.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-04
The filing discloses entry into subscription agreements on July 31, 2026, whereby the Company will issue 800,000 Class A ordinary shares to three accredited investors at $10.00 per share for $8 million in aggregate gross proceeds, contingent upon consummation of the Merger with Goodvision. The shares are offered in reliance on Section 4(a)(2) and Regulation D exemptions, constituting an unregistered private placement. This is a material dilutive equity issuance in connection with a SPAC business combination.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-04
Tim Pickett resigned from all positions including director and Chief Executive Officer of Kindly LLC effective August 3, 2026. The filing discloses a separation agreement with severance payment of $911,468.58, acceleration of unvested equity awards, and extended insurance coverage. This is a material executive departure involving a senior officer with significant severance and equity acceleration.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-08-04
The filing discloses the completion of a material acquisition on August 3, 2026, whereby Cycurion acquired substantially all assets of Kustom Entertainment's video-solutions division for aggregate consideration of $1.25M cash, $4.25M secured promissory note, up to $1M earnout, and $600K in Series H Preferred Stock. The acquisition is expected to add over $5M in annual revenue and $1.2M in EBITDA, bringing the company's pro forma revenue run rate to approximately $30M. Item 1.01 and Item 2.01 explicitly document entry into and completion of this material definitive agreement and asset acquisition.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-08-04
NextTrip entered into a Securities Purchase Agreement on July 31, 2026, to issue 89,430 shares of common stock to settle $144,876.71 in unpaid board compensation owed to five directors (four former, one current). Item 3.02 explicitly discloses this as an unregistered sale of equity securities under Section 4(a)(2) and Regulation D Rule 506. The issuance converts debt to equity at $1.62 per share, representing a dilutive capital transaction typical of small-cap companies raising cash or settling obligations through equity.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 92%
filed 2026-08-04
The filing discloses approval of a Retention Plan and Retention Agreement under Item 5.02(e), establishing compensatory arrangements for key employees and directors. The plan provides retention incentives tied to base salary or Board fees upon a Change in Control and salary increases during periods of Insolvency. This is a material disclosure of executive and director compensation arrangements affecting multiple participants.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-08-04
The filing discloses results of the 2026 Annual Meeting of Shareholders held on July 30, 2026, with detailed voting outcomes on four proposals: election of six directors, amendment to the 2019 Omnibus Incentive Plan to increase shares by 200,000, ratification of Cherry Bekaert as independent auditor, and an advisory vote on named executive officer compensation. Item 5.07 explicitly presents the vote tallies for each proposal, which is the core disclosure of shareholder voting results.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-04
Item 2.02
Pinterest announced its Q2 2026 financial results on August 4, 2026, disclosing revenue of $1,180 million (18% growth), net loss of $47 million, Adjusted EBITDA of $311 million, and record 640 million monthly active users. The press release is attached as Exhibit 99.1 and includes forward guidance for Q3 2026. This is a standard quarterly earnings release filed under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-08-04
Item 2.02
Marathon Petroleum Corporation issued a press release on August 4, 2026, announcing its financial results for the quarter ended June 30, 2026, disclosing net income of $5.1 billion ($17.73 per diluted share) and adjusted EBITDA of $8.5 billion. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the canonical Item for earnings disclosures.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
Item 2.02 discloses Skyward Specialty Insurance Group's quarterly and fiscal period results for the quarter and six months ended June 30, 2026, with a press release furnished as Exhibit 99.1. The press release presents comprehensive financial results including managed premiums ($1,058.7M), gross written premiums ($740.6M), net income ($49.0M), diluted operating earnings per share ($1.30), combined ratios (89.5%), and other key metrics, along with management commentary on performance. This is a standard earnings release disclosure material to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
Aptiv PLC issued a press release on August 4, 2026 reporting financial results for the quarter ended June 30, 2026, disclosing Q2 and year-to-date revenue of $3.3 billion and $6.3 billion respectively, net income from continuing operations, adjusted EBITDA, diluted EPS, and full-year 2026 guidance. This is a standard quarterly earnings release filed under Item 2.02 with the press release attached as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
Marqeta issued a press release on August 4, 2026 announcing Q2 2026 financial results with Net Revenue of $176 million (17% YoY growth), Gross Profit of $122 million (17% YoY growth), and GAAP Net Income of $8 million, achieving profitability for the second consecutive quarter.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-08-04
Item 5.02
Najuma Atkinson notified the Board of her intent to resign from the Board effective August 3, 2026, relinquishing her role as Chair of the Compensation Committee and member of the Nomination and Governance Committee.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-08-04
Item 8.01
The Board approved on August 3, 2026 a $150 million share repurchase program for Marqeta's Class A common stock, reflecting the company's capital allocation strategy.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
USA Compression Partners issued a press release on August 4, 2026, disclosing its financial and operating results for second-quarter 2026, including total revenues of $342.1 million, net income of $45.7 million, Adjusted EBITDA of $193.2 million, and Distributable Cash Flow of $125.3 million, along with full-year 2026 guidance. This is a standard quarterly earnings release furnished as Exhibit 99.1 under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-04
Item 2.02
Bristow Group Inc. issued a press release on August 4, 2026, disclosing second quarter 2026 financial results, including total revenues of $411.8 million, net income of $21.2 million ($0.70 per diluted share), and Adjusted EBITDA of $79.8 million, along with a presentation scheduled for August 5, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-08-04
Item 5.02
The filing's principal disclosed action is the appointment of Darin Harper, the Company's Chief Financial Officer, as Chief Executive Officer effective August 3, 2026, following Tarun Lal's retirement. While the filing also discloses Lal's departure, Harper's appointment as CEO—a critical leadership role—is the dominant event. The filing extensively details Harper's background, compensation package ($650,000 base salary, 100% target bonus, 115% LTIP target, and a $6.5 million one-time equity grant), and employment agreement terms, reflecting the materiality of this executive succession to investors.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-04
Item 2.02
Item 2.02 discloses Athene Holding Ltd.'s financial results for Q2 2026 (ended June 30, 2026) through Apollo Global Management's earnings presentation. The filing furnishes detailed quarterly financial statements, segment earnings, AUM metrics, and key performance indicators (FRE of $785M, SRE of $877M, net income of $1.3B), which are material to investors' assessment of the registrant's financial condition and operating performance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-04
Item 2.02
Voya Financial disclosed its second-quarter 2026 financial results on August 4, 2026, reporting net income of $90 million ($0.97 per diluted share) and after-tax adjusted operating earnings of $140 million ($1.51 per diluted share), along with segment performance, capital deployment information, and forward-looking guidance.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-08-04
Item 8.01
HomeTrust Bancshares announced completion of a 5% stock repurchase program (870,000 shares at $44.49 average price) and authorization of a new 5% repurchase program (832,000 shares). Stock repurchases are a form of return of capital to shareholders and fall within the dividend_distribution category, which encompasses share-repurchase programs. The disclosure is material as it reflects capital allocation decisions affecting shareholder value.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-08-04
Item 6.04
The filing discloses a distribution to certificateholders (Class B) of an additional principal payment of $912,584.60 made on July 29, 2026, resulting from curtailment payments on underlying mortgage loans. While the Item 6.04 caption references "Failure to Make a Required Distribution," the actual disclosure describes a distribution that was made (albeit with a revision/correction), making this fundamentally a dividend_distribution event. The materiality is clear given the specific dollar amount and the correction to certificateholder payments in a mortgage trust structure.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
Freshworks issued a press release on August 4, 2026 announcing Q2 2026 financial results, including total revenues of $237.4 million (16% YoY growth), positive GAAP net income of $3.2 million (first quarter of GAAP profitability in 2026), and raised full-year 2026 estimates.
View raw filing on EDGAR →
8-K
Workforce Reduction
confidence 95%
filed 2026-08-04
Item 2.05
Freshworks announced a restructuring plan in May 2026 to streamline organizational efforts and product development, with $7.0 million in restructuring charges primarily associated with employee severance and benefit costs recognized in H1 2026, substantially complete as of June 30, 2026.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
MPLX LP issued a press release on August 4, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing net income of $1.1 billion, adjusted EBITDA of $1.8 billion, and distributable cash flow of $1.5 billion. The filing explicitly states "On August 4, 2026, MPLX LP issued a press release announcing its financial results for the quarter ended June 30, 2026" and the press release is furnished as Exhibit 99.1, which is the standard format for earnings releases under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-08-04
Item 2.02
Sunoco LP issued a news release on August 4, 2026 announcing second quarter 2026 financial results, including net income of $283 million, Adjusted EBITDA of $996 million, and Distributable Cash Flow of $608 million, along with an increase in full-year 2026 Adjusted EBITDA guidance by $400 million to $3.5–$3.7 billion.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-08-04
Item 2.02
The filing discloses Eve Holding, Inc.'s second quarter 2026 financial results via a press release attached as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition). This is a standard earnings release disclosure, which is material to investors as it provides periodic financial performance information.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-08-04
Item 2.02
Thryv Holdings, Inc. issued a press release announcing its financial results for the six months ended June 30, 2026 (Q2 2026), disclosing revenue of $150.7 million, net loss of $16.7 million, and Adjusted EBITDA metrics, along with forward guidance and announcement of the Thryv Growth Platform. The disclosure includes consolidated financial statements, balance sheets, cash flows, and segment information.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-08-04
Item 7.01
TXO Partners declared a quarterly distribution of $0.40 per common unit for Q2 2026, payable on August 21, 2026. The press release explicitly announces this distribution declaration, which is the core disclosure in Item 7.01. As a master limited partnership, distributions to unitholders are a material recurring event that directly affects investor returns and is central to the partnership's investment thesis.
View raw filing on EDGAR →